CEACAM5 and neoplasm: CAR-engineered CIK cells show improved tumour specificity indicated by increased IFN-γ secretion upon contact to CEA+ compared to CEA− tumour cells, while nonmodified CIK cells do not increase IFN-γ in presence of CEA+ compared to CEA− tumour cells.